Prime Medicine, Inc.
PRME
$3.27
-$0.03-0.91%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 135.50M | 177.68M | 213.29M | 101.75M | 144.26M |
| Total Receivables | -- | -- | -- | 120.00K | 17.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.97M | 2.94M | 2.49M | 3.03M | 2.95M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 421.00K | 674.00K | 15.63M | 16.39M | 16.54M |
| Total Current Assets | 137.89M | 181.29M | 231.41M | 121.29M | 163.77M |
|
|
|||||
| Total Current Assets | 137.89M | 181.29M | 231.41M | 121.29M | 163.77M |
| Net Property, Plant & Equipment | 142.15M | 146.75M | 139.92M | 144.03M | 150.34M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.69M | 14.69M | 13.69M | 13.69M | 14.06M |
| Total Assets | 294.73M | 342.73M | 385.01M | 279.01M | 328.16M |
|
|
|||||
| Total Accounts Payable | 12.33M | 8.89M | 9.35M | 6.38M | 10.03M |
| Total Accrued Expenses | 5.95M | 10.90M | 8.94M | 11.04M | 6.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.55M | 8.14M | 7.71M | 7.26M | 6.86M |
| Total Finance Division Other Current Liabilities | 9.47M | 9.53M | 9.01M | 9.43M | 11.25M |
| Total Other Current Liabilities | 9.47M | 9.53M | 9.01M | 9.43M | 11.25M |
| Total Current Liabilities | 36.29M | 37.45M | 35.02M | 34.11M | 34.29M |
|
|
|||||
| Total Current Liabilities | 36.29M | 37.45M | 35.02M | 34.11M | 34.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 105.97M | 108.29M | 110.42M | 112.48M | 114.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 75.78M | 76.13M | 77.75M | 71.56M | 72.66M |
| Total Liabilities | 218.03M | 221.87M | 223.19M | 218.15M | 221.24M |
|
|
|||||
| Common Stock & APIC | 1.01B | 1.01B | 1.00B | 852.56M | 846.04M |
| Retained Earnings | -937.48M | -888.35M | -842.28M | -791.69M | -739.10M |
| Treasury Stock & Other | -1.00K | 82.00K | 33.00K | -10.00K | -15.00K |
| Total Common Equity | 76.70M | 120.87M | 161.82M | 60.86M | 106.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 76.70M | 120.87M | 161.82M | 60.86M | 106.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 76.70M | 120.87M | 161.82M | 60.86M | 106.92M |
|
|
|||||